Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT

Tobramycin is a potent antimicrobial aminoglycoside and its effective delivery by encapsulation within nanoparticle carriers could increase its activity against infections through a combination of sustained release and enhanced uptake. Effective antimicrobial therapy against a clinically relevant mo...

Full description

Bibliographic Details
Main Authors: Marcus Hill, Richard N. Cunningham, Rania M. Hathout, Christopher Johnston, John G. Hardy, Marie E. Migaud
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:Journal of Functional Biomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4983/10/2/26
_version_ 1828109527527981056
author Marcus Hill
Richard N. Cunningham
Rania M. Hathout
Christopher Johnston
John G. Hardy
Marie E. Migaud
author_facet Marcus Hill
Richard N. Cunningham
Rania M. Hathout
Christopher Johnston
John G. Hardy
Marie E. Migaud
author_sort Marcus Hill
collection DOAJ
description Tobramycin is a potent antimicrobial aminoglycoside and its effective delivery by encapsulation within nanoparticle carriers could increase its activity against infections through a combination of sustained release and enhanced uptake. Effective antimicrobial therapy against a clinically relevant model bacteria (<i>Pseudomonas aeruginosa</i>) requires sufficient levels of therapeutic drug to maintain a drug concentration above the microbial inhibitory concentration (MIC) of the bacteria. Previous studies have shown that loading of aminoglycoside drugs in poly(lactic-co-glycolic) acid (PLGA)-based delivery systems is generally poor due to weak interactions between the drug and the polymer. The formation of complexes of tobramycin with dioctylsulfosuccinate (AOT) allows the effective loading of the drug in PLGA-nanoparticles and such nanoparticles can effectively deliver the antimicrobial aminoglycoside with retention of tobramycin antibacterial function.
first_indexed 2024-04-11T11:04:52Z
format Article
id doaj.art-20ad67632b364dfdac591ae33b93054e
institution Directory Open Access Journal
issn 2079-4983
language English
last_indexed 2024-04-11T11:04:52Z
publishDate 2019-06-01
publisher MDPI AG
record_format Article
series Journal of Functional Biomaterials
spelling doaj.art-20ad67632b364dfdac591ae33b93054e2022-12-22T04:28:24ZengMDPI AGJournal of Functional Biomaterials2079-49832019-06-011022610.3390/jfb10020026jfb10020026Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOTMarcus Hill0Richard N. Cunningham1Rania M. Hathout2Christopher Johnston3John G. Hardy4Marie E. Migaud5School of Pharmacy, Queen’s University Belfast, Belfast BT7 1NN, UKSchool of Pharmacy, Queen’s University Belfast, Belfast BT7 1NN, UKDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, EgyptSchool of Pharmacy, Queen’s University Belfast, Belfast BT7 1NN, UKDepartment of Chemistry, Lancaster University, Lancaster, Lancashire LA1 4YB, UKSchool of Pharmacy, Queen’s University Belfast, Belfast BT7 1NN, UKTobramycin is a potent antimicrobial aminoglycoside and its effective delivery by encapsulation within nanoparticle carriers could increase its activity against infections through a combination of sustained release and enhanced uptake. Effective antimicrobial therapy against a clinically relevant model bacteria (<i>Pseudomonas aeruginosa</i>) requires sufficient levels of therapeutic drug to maintain a drug concentration above the microbial inhibitory concentration (MIC) of the bacteria. Previous studies have shown that loading of aminoglycoside drugs in poly(lactic-co-glycolic) acid (PLGA)-based delivery systems is generally poor due to weak interactions between the drug and the polymer. The formation of complexes of tobramycin with dioctylsulfosuccinate (AOT) allows the effective loading of the drug in PLGA-nanoparticles and such nanoparticles can effectively deliver the antimicrobial aminoglycoside with retention of tobramycin antibacterial function.https://www.mdpi.com/2079-4983/10/2/26biomedical applicationscolloidsdrug delivery systemsnanoparticlesantimicrobial
spellingShingle Marcus Hill
Richard N. Cunningham
Rania M. Hathout
Christopher Johnston
John G. Hardy
Marie E. Migaud
Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
Journal of Functional Biomaterials
biomedical applications
colloids
drug delivery systems
nanoparticles
antimicrobial
title Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
title_full Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
title_fullStr Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
title_full_unstemmed Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
title_short Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
title_sort formulation of antimicrobial tobramycin loaded plga nanoparticles via complexation with aot
topic biomedical applications
colloids
drug delivery systems
nanoparticles
antimicrobial
url https://www.mdpi.com/2079-4983/10/2/26
work_keys_str_mv AT marcushill formulationofantimicrobialtobramycinloadedplgananoparticlesviacomplexationwithaot
AT richardncunningham formulationofantimicrobialtobramycinloadedplgananoparticlesviacomplexationwithaot
AT raniamhathout formulationofantimicrobialtobramycinloadedplgananoparticlesviacomplexationwithaot
AT christopherjohnston formulationofantimicrobialtobramycinloadedplgananoparticlesviacomplexationwithaot
AT johnghardy formulationofantimicrobialtobramycinloadedplgananoparticlesviacomplexationwithaot
AT marieemigaud formulationofantimicrobialtobramycinloadedplgananoparticlesviacomplexationwithaot